Nu-Med Plus (NUMD) Enterprise Value Growth (1y) (2012 - 2025)
Nu-Med Plus (NUMD) Enterprise Value Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.14% |
| Sep 30, 2025 | 51.79% |
| Jun 30, 2025 | 78.64% |
| Mar 31, 2025 | 62.67% |
| Dec 31, 2024 | 65.13% |
| Sep 30, 2024 | 63.56% |
| Jun 30, 2024 | 86.51% |
| Mar 31, 2024 | 88.01% |
| Dec 31, 2023 | 90.70% |
| Sep 30, 2023 | -1,665.61% |
| Mar 31, 2023 | -1,990.22% |
| Dec 31, 2022 | -526.94% |
| Sep 30, 2022 | 98.03% |
| Mar 31, 2022 | 98.18% |
| Dec 31, 2021 | 93.81% |
| Sep 30, 2021 | -1.09% |
| Jun 30, 2021 | -1,092.78% |
| Mar 31, 2021 | -659.85% |
| Dec 31, 2020 | -2,562.89% |
| Sep 30, 2020 | 24.71% |